Skip to Main Content

Author Details

Saurabh Asthana
University of California San Francisco
2000
27
22
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
32681145Ribosome profiling reveals a functional role for autophagy in mRNA translational control.Commun Biol2020
32681145Ribosome profiling reveals a functional role for autophagy in mRNA translational control.Commun Biol2020
33214553Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis.Oncogenesis2020
33214553Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis.Oncogenesis2020
30643286Translation control of the immune checkpoint in cancer and its therapeutic targeting.Nat Med2019
30643286Translation control of the immune checkpoint in cancer and its therapeutic targeting.Nat Med2019
31088841Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.Cancer Discov2019
31088841Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.Cancer Discov2019
29942093A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.Nat Med2018
29942093A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.Nat Med2018
27869830Inactivation of Capicua drives cancer metastasis.Nat Genet2017
28559012Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient.Oral Oncol2017
28490572Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis.Blood2017
28287179Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution.Sci Rep2017
28215705KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.Cell2017
27869830Inactivation of Capicua drives cancer metastasis.Nat Genet2017
28207875Correction: Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1.PLoS One2017
28099461Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1.PLoS One2017
28215705KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.Cell2017
28099461Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1.PLoS One2017
28287179Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution.Sci Rep2017
28207875Correction: Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1.PLoS One2017
28490572Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis.Blood2017
28559012Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient.Oral Oncol2017
27450084Combined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcoma.Proc Natl Acad Sci U S A2016
27450084Combined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcoma.Proc Natl Acad Sci U S A2016
26619011Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.Nat Biotechnol2016
26619011Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.Nat Biotechnol2016
25665005The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.Nat Genet2015
25843712NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.Cell Rep2015
25665005The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.Nat Genet2015
26301689RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.Nat Med2015
26150578Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course.J Natl Compr Canc Netw2015
26301689RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.Nat Med2015
26150578Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course.J Natl Compr Canc Netw2015
25843712NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.Cell Rep2015
24336570Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.Science2014
24336570Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.Science2014
24550319Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.Proc Natl Acad Sci U S A2014
24934408Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.Cancer Discov2014
24934408Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.Cancer Discov2014
24550319Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.Proc Natl Acad Sci U S A2014
17571346Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.Nature2007
17640883Widely distributed noncoding purifying selection in the human genome.Proc Natl Acad Sci U S A2007
17571346Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.Nature2007
18166073Analysis of sequence conservation at nucleotide resolution.PLoS Comput Biol2007
18166073Analysis of sequence conservation at nucleotide resolution.PLoS Comput Biol2007
17640883Widely distributed noncoding purifying selection in the human genome.Proc Natl Acad Sci U S A2007
15680511A limited role for balancing selection.Trends Genet2005
15680511A limited role for balancing selection.Trends Genet2005
  • 1 - 50 of 54

Recommended Authors

Hannah Carter
University of California San Diego
Career Start Year 2008
Number of shared co-authors 12
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 3
Jasmin Coulombe-Huntington
Institute for Research in Immunology and Cancer, Universite de Montreal
Career Start Year 2007
Number of shared co-authors 2
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 5
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 5
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 7
David Jones
Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 5
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 9
Robert C Onofrio
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 27
Han Liang
MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 14
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 8
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 26
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 3
Peter J Campbell
Wellcome Sanger Institute
Career Start Year 2003
Number of shared co-authors 17
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 21
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 11
Jon Teague
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 7
Stacey Gabriel
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 45
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 10
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 41
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 42
Rachel Karchin
Johns Hopkins University
Career Start Year 1998
Number of shared co-authors 17
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 9
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 32
Adam Butler
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 18
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 9
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 10
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 34

Collaborators

Trever G Bivona
University of California san francisco
Co-authored papers 8
Victor Olivas
University of California san francisco
Co-authored papers 7
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Luping Lin
Incyte Research Institute, Incyte Corporation
Co-authored papers 5
Adam B Olshen
12224University of California san francisco
Co-authored papers 5
Collin M Blakely
University of California san francisco
Co-authored papers 4
Eric A Collisson
University of California san francisco
Co-authored papers 4
Elton Chan
University of California san francisco
Co-authored papers 4
Shamil R Sunyaev
Harvard Medical School
Co-authored papers 4
Evangelos Pazarentzos
University of California san francisco
Co-authored papers 4
John A Stamatoyannopoulos
Altius Institute for Biomedical Sciences
Co-authored papers 3
Gorjan Hrustanovic
University of California san francisco
Co-authored papers 3
Dana S Neel
Stanford University School of Medicine
Co-authored papers 3
Jenny Jiacheng Yan
Helen Diller Comprehensive Cancer Center, University of California san francisco
Co-authored papers 3
Joseph L DeRisi
University of California San Francisco
Co-authored papers 2
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Matthew A Gubens
University of California san francisco
Co-authored papers 2
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Nicholas D Socci
Co-authored papers 2
William Stafford Noble
Co-authored papers 2
Brett E Johnson
Co-authored papers 2
Catherine C Smith
University of California San Francisco
Co-authored papers 2
Sourav Bandyopadhyay
University of California San Francisco
Co-authored papers 2
Neil P Shah
University of California San Francisco
Co-authored papers 2
Mark Gerstein
Yale University
Co-authored papers 1
Yijun Ruan
Co-authored papers 1
Kayla E Smith
Co-authored papers 1
Daryl J Thomas
University of California at Santa Cruz
Co-authored papers 1
Madhavan Ganesh
Co-authored papers 1
Ross C Hardison
Co-authored papers 1
Release 1.2